Purpose of the study
Observational studies have noted very high rates of low serum 25-hydroxyvitamin D [25(OH)D3] levels in both general and HIVinfected populations. In HIV-infected patients, low 25(OH)D3 levels are secondary to a combination of usual risk factors and HIVspecific risk factors, like antiretroviral therapy [1] . The objective of our study is to analyse the magnitude of vitamin D deficiency or insufficiency and the role of various factors such as age, sex, ethnicity, season, and antiretroviral medications in our cohort of HIV-infected patients.
Methods
We prospectively collected data on 25-hydroxyvitamin D levels sampled between January 2009 and June 2011 from our cohort of 930 HIV-infected patients. Vitamin D dosage was performed using immunoassay ('Diasorin' -Saluggia, Italy). We divided vitamin D levels into 3 categories: 25-hydroxyvitamin D levels B20 mg/nl were considered deficient, insufficient between 20 and 29 ng/ml. Levels ]30 ng/ml were defined as normal [2] . Data on demographic features (age, ethnicity, season, heterosexuality vs homosexuality), clinical features and laboratory findings (CD4 cell count, viral load, HAART, BMI) were collected from patients' medical records using our institutional database 'Medical explorer v3r9, 2009'.
Summary of results
Overall, 848 patients were included in our study (Table 1) . 
Conclusion
Vitamin D deficiency is frequent in HIV-infected populations (69.5%). Patients on antiretroviral therapy are at higher risk of vitamin D deficiency. In our cohort, black women and dosage during winter were also independent risk factors for low vitamin D levels.
